Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

IDH1 mutation contributes to myeloid dysplasia in mice by disturbing heme biosynthesis and erythropoiesis

Blood (2021) 137 (7): 945–958.

https://doi.org/10.1182/blood.2020007075

Published: 2021

Includes: Supplemental data

Journal Articles

Glucocorticoids enhance the antileukemic activity of FLT3 inhibitors in FLT3-mutant acute myeloid leukemia

Melat T. Gebru, Jennifer M. Atkinson, Megan M. Young, Lijun Zhang, Zhenyuan Tang, Zhenqiu Liu, Pinyi Lu, Christopher M. Dower, Longgui Chen, Charyguly Annageldiyev, Arati Sharma, Yuka Imamura Kawasawa, Zhongming Zhao, Barbara A. Miller, David F. Claxton, Hong-Gang Wang

Blood (2020) 136 (9): 1067–1079.

https://doi.org/10.1182/blood.2019003124

Published: 2020

Includes: Supplemental data

Journal Articles

A Novel Scoring System, the Cord Blood Apgar, Predicts Engraftment After Cord Blood Transplantation: Optimization of Selection of Cord Blood Units (CBUs) for Transplantation

Kristin M. Page, MD, Lijun Zhang, PhD, Adam M Mendizabal, Tracy Gentry, Andrew Balber, PhD, Joanne Kurtzberg, MD

Blood (2010) 116 (21): 351.

https://doi.org/10.1182/blood.V116.21.351.351

Published: 2010

Journal Articles

Association of High Levels of Free Light Chain and the Presence of Igh Translocations in Multiple Myeloma and Prognostic Implications.

Shaji Kumar, Lijun Zhang, Angela Dispenzieri, Scott Van Wier, Jerry Katzmann, Melissa Snyder, Emily Blood, Roberta DeGoey, Kim Henderson, Arthur Bradwell, Robert Kyle, Philip Greipp, S. Vincent Rajkumar, Rafael Fonseca

Blood (2008) 112 (11): 1677.

https://doi.org/10.1182/blood.V112.11.1677.1677

Published: 2008

Journal Articles

Response Duration with Initial Therapy Is a Major Predictor of Overall Survival in Multiple Myeloma: Analysis from Multiple Phase III ECOG Clinical Trials

Shaji Kumar, MD, Lijun Zhang, Angela Dispenzieri, MD, Sagar Lonial, MD, Rafat Abonour, Leonard Heffner, Natalie Scott Callander, MD, David Siegel, Morie Gertz, Robert Kyle, MD, Philip R. Greipp, S. Vincent Rajkumar

Blood (2008) 112 (11): 5129.

https://doi.org/10.1182/blood.V112.11.5129.5129

Published: 2008

Journal Articles

Glucocorticoid Receptor Expression Correlates with Clinical Outcome in Myeloma Patients Treated with Glucocorticoid-Containing Regimens.

Shuo Ma, MD, PhD, Fenghuang Zhan, MD, PhD, Chunguang Ma, Michael Tessel, Lijun Zhang, S. Vincent Rajkumar, MD, Seema Singhal, Bart Barlogie, MD, John Shaughnessy, PhD, Steven T. Rosen, MD, Nancy Krett, PhD

Blood (2008) 112 (11): 1700.

https://doi.org/10.1182/blood.V112.11.1700.1700

Published: 2008

Journal Articles

Appraisal of immunoglobulin free light chain as a marker of response

Angela Dispenzieri, Lijun Zhang, Jerry A. Katzmann, Melissa Snyder, Emily Blood, Roberta DeGoey, Kimberly Henderson, Robert A. Kyle, Martin M. Oken, Arthur R. Bradwell, Philip R. Greipp

Blood (2008) 111 (10): 4908–4915.

https://doi.org/10.1182/blood-2008-02-138602

Published: 2008

Journal Articles

A Phase II Trial of Autologous Stem Cell Transplant (AHSCT) Followed by Mini-Allogeneic Stem Cell Transplant (AlloTx) for the Treatment of Multiple Myeloma: Analysis of ECOG E4A98.

David H. Vesole, MD, PhD, Lijun Zhang, MS, Neal Flomenberg, MD, Philip R. Greipp, MD, Hillard M. Lazarus, MD

Blood (2007) 110 (11): 3027.

https://doi.org/10.1182/blood.V110.11.3027.3027

Published: 2007

Journal Articles

Effect of Thrombotic Events on Overall Survival in Patients with Newly Diagnosed Myeloma: Analysis from a Randomized Phase III Trial of Thalidomide Plus Dexamethasone Versus Dexamethasone in Newly Diagnosed Multiple Myeloma (E1A00).

Shaji Kumar, MD, Lijun Zhang, Philip R. Greipp, MD, S. Vincent Rajkumar, MD

Blood (2007) 110 (11): 2734.

https://doi.org/10.1182/blood.V110.11.2734.2734

Published: 2007

Journal Articles

Phase II Study of R-CHOP Followed by 90 Y-Ibritumomab Tiuxetan in Untreated Mantle Cell Lymphoma: Eastern Cooperative Oncology Group Study E1499.

Mitchell R. Smith, MD, PhD, Lijun Zhang, Leo I. Gordon, MD, James Foran, MD, Brad Kahl, MD, Randy D. Gascoyne, MD, Ranjana Advani, MD, Elisabeth Paietta, MD, Edie Weller, PhD, Sandra J. Horning, MD

Blood (2007) 110 (11): 389.

https://doi.org/10.1182/blood.V110.11.389.389

Published: 2007

NARROW

IDH1 mutation contributes to myeloid dysplasia in mice by disturbing heme biosynthesis and erythropoiesis

Glucocorticoids enhance the antileukemic activity of FLT3 inhibitors in FLT3-mutant acute myeloid leukemia

A Novel Scoring System, the Cord Blood Apgar, Predicts Engraftment After Cord Blood Transplantation: Optimization of Selection of Cord Blood Units (CBUs) for Transplantation

Association of High Levels of Free Light Chain and the Presence of Igh Translocations in Multiple Myeloma and Prognostic Implications.

Response Duration with Initial Therapy Is a Major Predictor of Overall Survival in Multiple Myeloma: Analysis from Multiple Phase III ECOG Clinical Trials

Glucocorticoid Receptor Expression Correlates with Clinical Outcome in Myeloma Patients Treated with Glucocorticoid-Containing Regimens.

Appraisal of immunoglobulin free light chain as a marker of response

A Phase II Trial of Autologous Stem Cell Transplant (AHSCT) Followed by Mini-Allogeneic Stem Cell Transplant (AlloTx) for the Treatment of Multiple Myeloma: Analysis of ECOG E4A98.

Effect of Thrombotic Events on Overall Survival in Patients with Newly Diagnosed Myeloma: Analysis from a Randomized Phase III Trial of Thalidomide Plus Dexamethasone Versus Dexamethasone in Newly Diagnosed Multiple Myeloma (E1A00).

Phase II Study of R-CHOP Followed by 90 Y-Ibritumomab Tiuxetan in Untreated Mantle Cell Lymphoma: Eastern Cooperative Oncology Group Study E1499.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only